Pharmacogenetics in the Treatment of Pre-Eclampsia: Current Findings, Challenges and Perspectives
Pre-eclampsia (PE) is defined as pregnancy-induced hypertension and proteinuria, and is a major cause of maternal and perinatal morbidity and mortality. A large subgroup of pregnant women with PE is nonresponsive to antihypertensive drugs, including methyldopa, nifedipine and hydralazine. Pharmacoge...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Revisão |
| Jazyk: | angličtina |
| Vydáno: |
2017
|
| On-line přístup: | https://doi.org/10.2217/pgs-2016-0198 https://www.futuremedicine.com/doi/pdf/10.2217/pgs-2016-0198 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|